Charles River Laboratories International (CRL) News Today $189.78 +0.45 (+0.24%) (As of 11:57 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Sanctuary Advisors LLC Has $3.40 Million Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Sanctuary Advisors LLC cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 26.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,379 shares of the medical research company's stock aDecember 17 at 4:37 AM | marketbeat.comCautious Hold Rating for Charles River Labs Amid Stable Projections and Slight Price Target AdjustmentDecember 17 at 3:24 AM | markets.businessinsider.comLord Abbett & CO. LLC Buys 5,959 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Lord Abbett & CO. LLC boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 108,715 shares of the medDecember 16 at 5:40 AM | marketbeat.comVirtu Financial LLC Buys New Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Virtu Financial LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,051 shares of the medical research company's stDecember 15 at 5:03 AM | marketbeat.comBarclays PLC Lowers Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Barclays PLC reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 20.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 130,826 shares of the medical researchDecember 14, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Price Target Cut to $210.00 by Analysts at Bank of AmericaBank of America decreased their target price on Charles River Laboratories International from $220.00 to $210.00 and set a "neutral" rating for the company in a research note on Friday.December 13, 2024 | marketbeat.comTD Private Client Wealth LLC Lowers Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)TD Private Client Wealth LLC reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,342 shares of the medical reDecember 13, 2024 | marketbeat.comNational Bank of Canada FI Purchases 6,627 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)National Bank of Canada FI grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 45.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 21,216 shares of the medical research company's stock afterDecember 13, 2024 | marketbeat.com4,902 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Neo Ivy Capital ManagementNeo Ivy Capital Management purchased a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,902 shares ofDecember 12, 2024 | marketbeat.comGould Capital LLC Acquires New Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Gould Capital LLC bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 6,217 shares of the medical research company's stock, valued at approximateDecember 10, 2024 | marketbeat.comState Street Corp Buys 41,421 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)State Street Corp boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,130,279 shares of the medical research companyDecember 10, 2024 | marketbeat.comStifel Financial Corp Decreases Position in Charles River Laboratories International, Inc. (NYSE:CRL)Stifel Financial Corp decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 9.3% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 100,593 shares of the medical research company's stock after sellingDecember 10, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Trimmed by Fmr LLCFmr LLC decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 70.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 134,292 shares of the medical research company's stock afterDecember 10, 2024 | marketbeat.comQuadrature Capital Ltd Sells 41,941 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Quadrature Capital Ltd cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 92.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,470 shares of the medical research companyDecember 9, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Quantinno Capital Management LPQuantinno Capital Management LP grew its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 27.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,706 sharesDecember 9, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Janus Henderson Group PLCJanus Henderson Group PLC raised its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 7.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,018 shares of the medDecember 9, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Position Increased by iA Global Asset Management Inc.iA Global Asset Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5,383.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,030 shareDecember 8, 2024 | marketbeat.comCharles River Introduces Global Biotech Incubator ProgramDecember 5, 2024 | finance.yahoo.comCentiva Capital LP Takes $1.43 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Centiva Capital LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,265 shares of the medical researchDecember 4, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange CommissioDecember 4, 2024 | marketbeat.comCharles River Laboratories to Present at Evercore ISI Investor ConferenceDecember 2, 2024 | gurufocus.comZacks Research Issues Negative Forecast for CRL EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Zacks Research cut their Q4 2024 EPS estimates for Charles River Laboratories International in a research report issued on Wednesday, November 27th. Zacks Research analyst R. Department now anticipates that the medical reseDecember 2, 2024 | marketbeat.comBellevue Group AG Decreases Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Bellevue Group AG lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 68.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,115 sharDecember 1, 2024 | marketbeat.comAmerican Capital Management Inc. Sells 35,500 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)American Capital Management Inc. decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 19.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 147,800 shares of the medical resDecember 1, 2024 | marketbeat.comPDT Partners LLC Sells 3,500 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)PDT Partners LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 27.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,263 shares of the medical research company's stock after selliDecember 1, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Buys Shares of 14,800 Charles River Laboratories International, Inc. (NYSE:CRL)Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 14,800 shDecember 1, 2024 | marketbeat.comBNP Paribas Financial Markets Sells 48,659 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)BNP Paribas Financial Markets cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 38.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 79,171 shares of the medical research comDecember 1, 2024 | marketbeat.comQuantbot Technologies LP Purchases Shares of 8,169 Charles River Laboratories International, Inc. (NYSE:CRL)Quantbot Technologies LP acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 8,169 shares of the medical research company's stock,November 30, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Trims Position in Charles River Laboratories International, Inc. (NYSE:CRL)The Manufacturers Life Insurance Company trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 42.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional inveNovember 30, 2024 | marketbeat.comAre Wall Street Analysts Predicting Charles River Stock Will Climb or Sink?November 29, 2024 | msn.comCharles River Laboratories International, Inc. (NYSE:CRL) Position Increased by Financial Counselors Inc.Financial Counselors Inc. lifted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 26,592 shares of the medical research company's stock after buyNovember 29, 2024 | marketbeat.comFORA Capital LLC Sells 2,961 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)FORA Capital LLC reduced its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 32.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,026 shares of the medical reseNovember 28, 2024 | marketbeat.comMudita Advisors LLP Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Mudita Advisors LLP cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,707 shares of the medical research company's sNovember 27, 2024 | marketbeat.comCharles River Laboratories International Q3 Earnings TranscriptNovember 27, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 32,311 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Charles Schwab Investment Management Inc. raised its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 515,222 shares of the medical research coNovember 27, 2024 | marketbeat.comCharles River Laboratories International Inc (CRL)'s Winning Formula: Financial Metrics and ...November 26, 2024 | gurufocus.comHorizon Kinetics Asset Management LLC Sells 45,619 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Horizon Kinetics Asset Management LLC decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 28.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1November 25, 2024 | marketbeat.comCitigroup Inc. Has $46.51 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Citigroup Inc. lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 236,141 shares of the medical research comNovember 25, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Reduce" from AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have received an average rating of "Reduce" from the fifteen analysts that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation,November 24, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 63,588 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)BNP PARIBAS ASSET MANAGEMENT Holding S.A. lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional iNovember 23, 2024 | marketbeat.comLathrop Investment Management Corp Cuts Position in Charles River Laboratories International, Inc. (NYSE:CRL)Lathrop Investment Management Corp lessened its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 16.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 25,414 shares of the medical researchNovember 22, 2024 | marketbeat.comKing Luther Capital Management Corp Sells 252,657 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)King Luther Capital Management Corp trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 79.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 65,689 shares of the medical reseaNovember 22, 2024 | marketbeat.comBrown Capital Management LLC Has $1.29 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Brown Capital Management LLC trimmed its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 67.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,546 shares of the mNovember 21, 2024 | marketbeat.comPremier Fund Managers Ltd Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Premier Fund Managers Ltd boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 56.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 250,000 shares of the medical research compNovember 20, 2024 | marketbeat.comNatixis Advisors LLC Lowers Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Natixis Advisors LLC trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,143 shares of the medicaNovember 20, 2024 | marketbeat.comCharles River Laboratories: Not The Right Time To Own At This Point In The CycleNovember 19, 2024 | seekingalpha.comThrivent Financial for Lutherans Sells 41,997 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Thrivent Financial for Lutherans cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 332,662 shares of the medical researchNovember 19, 2024 | marketbeat.comMawer Investment Management Ltd. Sells 32,693 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Mawer Investment Management Ltd. cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 44.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,860 shares of the medicalNovember 18, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Rating Lowered to Underperform at CLSACLSA lowered Charles River Laboratories International from a "hold" rating to an "underperform" rating and set a $164.00 price target on the stock. in a research note on Monday.November 18, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. boosted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 3.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 111,995 shares of the medical research comNovember 18, 2024 | marketbeat.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼1.030.59▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼117▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Illumina News Waters News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRL Stock Alerts